Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
562,474
-
Share change
-
+43,824
-
Total reported value
-
$109,355,839
-
Price per share
-
$194.24
-
Number of holders
-
116
-
Value change
-
+$8,370,033
-
Number of buys
-
48
-
Number of sells
-
42
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q1 2022
As of 31 Mar 2022,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
562,474 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, BROWN ADVISORY INC, RAYMOND JAMES & ASSOCIATES, Adviser Investments LLC, LPL Financial LLC, MURPHY CAPITAL MANAGEMENT INC, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
117
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.